Malignant infantile osteopetrosis in a 3-year-old Yemeni child: a case report

Saeed Thabet1,2, Mohammed Almajeedi2,3, Maged Mohammed2,3

  • 1Hematology and Internal Medicine Department, Faculty of Medicine, Taiz University of Medical Sciences, Taiz, Yemen.

Insights

Infantile malignant osteopetrosis (IMOP) is a rare genetic bone disorder. Early diagnosis via clinical, imaging, and bone marrow tests is crucial, especially in limited-resource settings.

Area of Science:

  • Pediatric Hematology
  • Skeletal Dysplasias
  • Genetic Bone Disorders

Background:

  • Infantile malignant osteopetrosis (IMOP) is a rare autosomal recessive disorder.
  • Characterized by osteoclast dysfunction leading to increased bone density.
  • Clinical features manifest from birth or infancy.

Observation:

  • A 3-year-old female presented with chronic anemia, hepatosplenomegaly, hypotonia, and visual impairment.
  • Blood tests revealed pancytopenia and hypocalcemia.
  • Radiology showed increased bone density and abnormal metaphyseal remodeling; bone marrow aspiration indicated hypocellularity.

Findings:

  • Diagnosis of IMOP confirmed through integrated clinical, radiological, and bone marrow findings.
  • The case highlights the diagnostic challenges and presentation of IMOP.

Implications:

  • Emphasizes the importance of a comprehensive diagnostic approach for IMOP.
  • Highlights the utility of clinical, radiological, and bone marrow aspiration in resource-limited settings.
  • Underscores the rarity and severity of infantile malignant osteopetrosis.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
411
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
224
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K